ArticleBlood2015
How should we assess the value of innovative drugs in oncology? Lessons from cost-effectiveness analyses.
Vinay Prasad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it
ArticleBlood2015
Vinay Prasad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.